Rock Creek adds IASO Advisors' GP and co-founder to board

Sarasota, Florida-based Rock Creek Pharmaceuticals Inc, a drug developer focused on treating chronic inflammatory conditions, has appointed Robert Scannell to its board of directors. Scannel is the co-founder and general partner of investment firm IASO Advisors LLC.

19 November 2015•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles